Avian influenza A(H7N9) virus infection in 2 travelers returning from China to Canada, January 2015

Emerging Infectious Diseases

Volumn 22, Issue 1, 2016, Pages 71-74

  Skowronski, Danuta M ^a,b   Chambers, Catharine ^a   Gustafson, Reka ^b,c   Purych, Dale B ^b,d   Tang, Patrick ^a,b   Bastien, Nathalie ^e   Krajden, Mel ^a,b   Li, Yan ^e,f  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c VANCOUVER COASTAL HEALTH   (Canada)

^d LifeLabs Medical Laboratory Services   (Canada)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ADULT; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA A(H7N9) VIRUS INFECTION; CASE REPORT; EMPORIATRICS; FEMALE; FOLLOW UP; HEMAGGLUTINATION TEST; INFLUENZA A VIRUS (H7N9); MALE; MIDDLE AGED; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEQUENCE ANALYSIS; THROAT CULTURE; VIRUS DETECTION; VIRUS ISOLATION; ANIMAL; BRITISH COLUMBIA; CHINA; COMMUNICABLE DISEASES, EMERGING; EPIDEMIC; HUMAN; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION;

ANIMALS; BRITISH COLUMBIA; CHINA; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; FEMALE; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED;

EID: 84950296379     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2201.151330     Document Type: Article

References (15)

1. Lam TT, Zhou B, Wang J, Chai Y, Shen Y, Chen X, et al. Dissemination, divergence and establishment of H7N9 influenza viruses in China. Nature. 2015;522:102–5.
2. European Centre for Disease Prevention and Control. Human infection with avian influenza A(H7N9) virus. Fourth update, February 2, 2015 [cited 2015 Jul 23]. http://ecdc.europa.eu/en/publications/Publications/RRA-Influenza-A-H7N9-update-four.pdf
3. To KKW, Chan JFW, Chen H, Li L, Yuen K-Y. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect Dis. 2013;13:809–21. http://dx.doi.org/10.1016/S1473-3099(13)70167-1
4. Skowronski DM, Li Y, Tweed SA, Tam TWS, Petric M, David ST, et al. Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ. 2007;176:47–53. http://dx.doi.org/10.1503/cmaj.060204
5. European Centre for Disease Prevention and Control. Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA)—influenza. 2014 [cited 2015 Sep 6]. http://ecdc.europa.eu/en/publications/Publications/influenza-RAGIDA-2014.pdf
6. Centers for Disease Control and Prevention. Modified hemagglutination-inhibition (HI) assay using horse RBCS for serologic detection of antibodies to H7 subtype avian influenza virus in human sera. Version 1 [cited 2015 July 23]. https://consise.tghn.org/site_media/media/articles/160713_Modified_Hemagglutination_Inhibition_Assay_Using_Horse_ RBCs.pdf.
7. Skowronski DM, Janjua NZ, De Serres G, Purych D, Gilca V, Scheifele DW, et al. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2)v. J Infect Dis. 2012;206:1852–61. http://dx.doi.org/10.1093/infdis/jis500
8. Skowronski DM, Chambers C, Sabaiduc S, Janjua NZ, Li G, Petric M, et al. Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence by age, during the 2013–2014 epidemic in Canada. J Infect Dis. 2015;211:109–14. http://dx.doi.org/10.1093/infdis/jiu366
9. Gao H-N, Lu H-Z, Cao B, Du B, Shang H, Gan J-H, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013;368:2277–85. http://dx.doi.org/10.1056/NEJMoa1305584
10. Zhang A, Huang Y, Tian D, Lau EH, Wan Y, Liu X, et al. Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013. Euro Surveill. 2013;18:20657.
11. Yang S, Chen Y, Cui D, Yao H, Lou J, Huo Z, et al. Avian-origin influenza A(H7N9) infection in influenza A(H7N9)–affected areas of China: a serological study. J Infect Dis. 2014;209:265–9. http://dx.doi.org/10.1093/infdis/jit430
12. Guo L, Zhang X, Yu X, Chen L, Zhou H, Gao X, et al. Human antibody responses to avian influenza A(H7N9) virus, 2013. Emerg Infect Dis. 2014;20:192–200. http://dx.doi.org/10.3201/eid2002.131094
13. Chen Z, Liu H, Lu J, Luo L, Li K, Liu Y, et al. Asymptomatic, mild, and severe influenza A(H7N9) virus infection in humans, Guangzhou, China. Emerg Infect Dis. 2014;20:1535–40. http://dx.doi.org/10.3201/eid2009.140424
14. Ip DK, Liao Q, Wu P, Gao Z, Cao B, Feng L, et al. Detection of mild to moderate influenza A/H7N9 infection by China’s national sentinel surveillance system for influenza-like illness: case series. BMJ. 2013;346:f3693. http://dx.doi.org/10.1136/bmj.f3693
15. Pabbaraju K, Tellier R, Wong S, Li Y, Bastien N, Tang JW. Full-genome analysis of avian influenza A(H5N1) virus from a human, North America, 2013. Emerg Infect Dis. 2014;20:887–91. http://dx.doi.org/10.3201/eid2005.140164